Japan Tissue Engineering Co., Ltd.
Tokyo Stock Exchange 7774.T
Japan Tissue Engineering Co., Ltd. Free Cash Flow Yield on January 14, 2025: 0.01%
-
Japan Tissue Engineering Co., Ltd. 52-week high Free Cash Flow Yield is 0.01% on December 23, 2024, which is 20.00% above the current Free Cash Flow Yield.
-
Japan Tissue Engineering Co., Ltd. 52-week low Free Cash Flow Yield is -4.59% on February 15, 2024, which is -91,820.00% below the current Free Cash Flow Yield.
-
Japan Tissue Engineering Co., Ltd. average Free Cash Flow Yield for the last 52 weeks is -0.85%.
| Date | Free Cash Flow Yield | Market Value Added (MVA) | Price to Book Ratio (P/B) | Price to Earnings Ratio (P/E) |
|---|
| CEO | Mr. Ken-Ichiro Hata D.D.S., Ph.D. |
| IPO Date | Dec. 28, 2007 |
| Location | Japan |
| Headquarters | 6-209-1 Miyakitadori |
| Employees | 211 |
| Sector | Health Care |
| Industries | |
Japan Tissue Engineering Co., Ltd. engages in the regenerative medicine business in Japan. The company operates through Regenerative Medicine Product, Regenerative Medicine Outsourcing, and Research and Development Support segments. It offers autologous cultured epidermis, cartilage, corneal epithelium, and oral mucosal epithelium to medical institutions for the purpose of medical treatment. The company also provides tissue-engineered medical products. In addition, it researches and develops human 3-dimensional cultured tissue models for use in the development of cosmetics and drugs for external use, as well as in research that employs skin and cornea tissues. Further, the company offers regenerative medicine contract development and manufacturing services. The company was founded in 1999 and is headquartered in Gamagori, Japan. Japan Tissue Engineering Co., Ltd. is a subsidiary of Teijin Limited.
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email